Acquired hemophilia should be evaluated in pediatric patients with bleeding and isolated prolonged aPTT. Immunosuppressive treatment should be initiated even in minor bleedings. Bypassing agents like rFVIIa can be used in children with success.
Keywords: Acquired hemophilia A; factor VIII deficiency; pediatric population; recombinant factor VII activated.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.